Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: A critical review directed at structural study-bias

[1]  T. Tomson,et al.  Teratogenic effects of antiepileptic drugs , 2008, Seizure.

[2]  H. Steinhausen,et al.  Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development , 2008, Developmental medicine and child neurology.

[3]  A. George,et al.  Intellectual and language functions in children of mothers with epilepsy , 2007, Epilepsia.

[4]  K. Meador,et al.  Cognitive/behavioral teratogenetic effects of antiepileptic drugs , 2007, Epilepsy & Behavior.

[5]  S. Vollset,et al.  Maternal Epilepsy and Offsprings' Adult Intelligence: A Population‐Based Study from Norway , 2007, Epilepsia.

[6]  P. Brocklehurst,et al.  Common antiepileptic drugs in pregnancy in women with epilepsy , 2007 .

[7]  M. Dhanaraj,et al.  Physical growth and psychomotor development of infants exposed to antiepileptic drugs in utero. , 2006, Neurology India.

[8]  R. Kälviäinen,et al.  The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children , 2006, Epilepsy & Behavior.

[9]  K. Meador,et al.  In utero antiepileptic drug exposure , 2006, Neurology.

[10]  A. Ornoy.  Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. , 2006, Reproductive toxicology.

[11]  E. Ben-Menachem,et al.  Role of valproate across the ages. Treatment of epilepsy in adults , 2006, Acta neurologica Scandinavica. Supplementum.

[12]  K. Meador,et al.  Antiepileptic drugs and neurodevelopment , 2006, Current neurology and neuroscience reports.

[13]  M. Eadie,et al.  Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry , 2006, European journal of neurology.

[14]  T. Tomson,et al.  Prenatal exposure to antiepileptic drugs , 2006, The Lancet.

[15]  M. Gissler,et al.  Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland. , 2006, International journal of epidemiology.

[16]  S. Kochen,et al.  Seizure control and treatment in pregnancy , 2006, Neurology.

[17]  E. Sheiner,et al.  Pregnancy and perinatal outcome in epileptic women: A population-based study , 2006, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[18]  E. Perucca.  Birth defects after prenatal exposure to antiepileptic drugs , 2005, The Lancet Neurology.

[19]  J. Clayton-Smith,et al.  Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[20]  P. Turnpenny,et al.  Characteristics of fetal anticonvulsant syndrome associated autistic disorder. , 2005, Developmental medicine and child neurology.

[21]  R. Kälviäinen,et al.  Children exposed to valproate in utero—Population based evaluation of risks and confounding factors for long-term neurocognitive development , 2005, Epilepsy Research.

[22]  L. Parker,et al.  Folic acid supplementation and social deprivation , 2005, Public Health Nutrition.

[23]  G. Baker,et al.  Neuropsychological effects of exposure to anticonvulsant medication in utero , 2005, Neurology.

[24]  L. Holmes,et al.  Increased rate of major malformations in offspring exposed to valproate during pregnancy , 2005, Neurology.

[25]  A. Aldenkamp,et al.  Educational Underachievement in Children With Epilepsy: A Model to Predict the Effects of Epilepsy on Educational Achievement , 2005, Journal of child neurology.

[26]  G. Baker,et al.  Epilepsy and social identity: the stigma of a chronic neurological disorder , 2005, The Lancet Neurology.

[27]  H. Saal,et al.  Valproate embryopathy: Clinical and cognitive profile in 5 siblings , 2005, American journal of medical genetics. Part A.

[28]  M. Okada,et al.  Physical and Psychomotor Development in the Offspring Born to Mothers with Epilepsy , 2004, Epilepsia.

[29]  J. Clayton-Smith,et al.  A note on Pierre Marie (1853–1940) , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[30]  E. Lieberman,et al.  The AED (antiepileptic drug) pregnancy registry: a 6-year experience. , 2004, Archives of neurology.

[31]  J. Ray,et al.  Evidence for suboptimal use of periconceptional folic acid supplements globally , 2004, BJOG : an international journal of obstetrics and gynaecology.

[32]  A. Pitkänen,et al.  Antiepileptic drugs in neuroprotection , 2004, Expert opinion on pharmacotherapy.

[33]  B. Källén,et al.  Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation‐wide, population‐based register study , 2004, Acta paediatrica.

[34]  V. Hiilesmaa,et al.  Normal intelligence in children with prenatal exposure to carbamazepine , 2004, Neurology.

[35]  M. Manfredi,et al.  Psychomotor development and general movements in offspring of women with epilepsy and anticonvulsant therapy. , 2003, Early human development.

[36]  C. Ikonomidou,et al.  Antiepileptic Drugs and Apoptosis in the Developing Brain , 2003, Annals of the New York Academy of Sciences.

[37]  A. Richens,et al.  Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop , 2003, Epilepsy Research.

[38]  J. Clayton-Smith,et al.  Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate , 2002, Seizure.

[39]  P. Genton,et al.  Epilepsy and women's issues: an update. , 2002, Epileptic disorders : international epilepsy journal with videotape.

[40]  E. Kajantie,et al.  Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility. , 2002, Neurology.

[41]  J. Jacobson,et al.  Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome. , 2002, Pediatrics.

[42]  J. Little,et al.  Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth , 2002, Journal of medical genetics.

[43]  R. K. Miller,et al.  Update on new developments in the study of human teratogens. , 2002, Teratology.

[44]  M. Bourgeois,et al.  Craniosynostosis and fetal exposure to sodium valproate. , 2001, Journal of neurosurgery.

[45]  B. Coull,et al.  The Teratogenicity of Anticonvulsant Drugs , 2001 .

[46]  R. Gardner,et al.  Microlissencephaly with cardiac, spinal and urogenital defects. , 2001, Clinical dysmorphology.

[47]  S. Pacia,et al.  Current Management of Epilepsy and Pregnancy: Fetal Outcome, Congenital Malformations, and Developmental Delay , 2001, Epilepsy & Behavior.

[48]  C. Kozma.  Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. , 2001, American journal of medical genetics.

[49]  D. Chadwick,et al.  Additional educational needs in children born to mothers with epilepsy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[50]  P. Turnpenny,et al.  A clinical study of 57 children with fetal anticonvulsant syndromes , 2000 .

[51]  H. Lou,et al.  Brain development, head circumference and medication , 2000, Acta paediatrica.

[52]  A. Dessens,et al.  Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems , 2000, Acta paediatrica.

[53]  S. Khoshbin,et al.  Intelligence and physical features of children of women with epilepsy. , 2000, Teratology.

[54]  T. Tomson,et al.  Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population‐based study , 2000, Developmental medicine and child neurology.

[55]  U. Lehmkuhl,et al.  Long‐Term Neuropsychological Consequences of Maternal Epilepsy and Anticonvulsant Treatment During Pregnancy for School‐Age Children and Adolescents , 1999, Epilepsia.

[56]  P. Turnpenny,et al.  Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene , 1999, Clinical genetics.

[57]  Bettina Samren.  Maternal Epilepsy and Pregnancy Outcome: a population-based study , 1998 .

[58]  J. Hersh,et al.  A male with fetal valproate syndrome and autism , 1997, Developmental medicine and child neurology.

[59]  A. Hofman,et al.  Maternal Use of Antiepileptic Drugs and the Risk of Major Congenital Malformations: A Joint European Prospective Study of Human Teratogenesis Associated with Maternal Epilepsy , 1997, Epilepsia.

[60]  A. Ornoy,et al.  Outcome of Children Born to Epileptic Mothers Treated With Carbamazepine During Pregnancy , 1997 .

[61]  G. Koren,et al.  Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. , 1997, American journal of medical genetics.

[62]  D. Rubin,et al.  In utero exposure to phenobarbital and intelligence deficits in adult men. , 1995, JAMA.

[63]  P. Mcelhatton.  The effects of benzodiazepine use during pregnancy and lactation. , 1994, Reproductive toxicology.

[64]  H. Steinhausen,et al.  The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors , 1994, Acta paediatrica.

[65]  H. Steinhausen,et al.  The psychological development of children of epileptic parents. I. Study design and comparative findings , 1994, Acta paediatrica.

[66]  R. Weksberg,et al.  Neurodevelopment of Children Exposed In Utero to Phenytoin and Carbamazepine Monotherapy , 1994 .

[67]  J. Kromberg,et al.  Fetal Valproate Syndrome: Clinical and Neuro‐developmental Features in Two Sibling Pairs , 1994 .

[68]  F. Ebbesen,et al.  Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. , 1993, Archives of disease in childhood.

[69]  T. Hedner,et al.  Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. , 1993, Neuropediatrics.

[70]  L. Holmes,et al.  The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. , 1992, Neurotoxicology and teratology.

[71]  D. Lindhout,et al.  Pregnancy and the Risk of Teratogenicity , 1992, Epilepsia.

[72]  R. Loewenson,et al.  Antiepileptics and the development of congenital anomalies. , 1992, Neurology.

[73]  C. J. Sells,et al.  Epilepsy in pregnancy: developmental outcome of offspring at 12 months. , 1992, Neurology.

[74]  A. Delgado-Escueta,et al.  Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. , 1992, Neurology.

[75]  M. Hadders‐Algra,et al.  Antiepileptic medication in pregnancy: Late effects on the children's central nervous system development , 1991, American journal of obstetrics and gynecology.

[76]  G. Mawer,et al.  Fetal phenytoin exposure, hypoplastic nails, and jitteriness. , 1991, Archives of disease in childhood.

[77]  J. R. Hughes,et al.  Advances in epileptology , 1990 .

[78]  E. Gaily,et al.  SPECIFIC COGNITIVE DYSFUNCTION IN CHILDREN WITH EPILEPTIC MOTHERS , 1990, Developmental medicine and child neurology.

[79]  V. Hiilesmaa,et al.  Head circumference in children of epileptic mothers: Contributions of drug exposure and genetic background , 1990, Epilepsy Research.

[80]  Kathleen A. Johnson,et al.  Pattern of Malformations in the Children of Women Treated with Carbamazepine during Pregnancy , 1990 .

[81]  E. Gaily,et al.  Intelligence of children of epileptic mothers. , 1988, The Journal of pediatrics.

[82]  M. Goto,et al.  Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk Factors , 1988, Epilepsia.

[83]  M. Goetting,et al.  Status epilepticus during labor. A case report. , 1987, The Journal of reproductive medicine.

[84]  C. Curry,et al.  The fetal valproate syndrome. , 1984, American journal of medical genetics.

[85]  S. Kaneko,et al.  100. The Physical and Mental Development of Infants Born to Mothers Treated with Antiepileptic Drugs , 1984 .

[86]  V. Hiilesmaa,et al.  Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome. , 1983, British medical journal.

[87]  J. Ellenberg,et al.  Maternal seizure disorder, outcome of pregnancy, and neurologic abnormalities in the children , 1982, Neurology.

[88]  V. Hiilesmaa,et al.  FETAL HEAD GROWTH RETARDATION ASSOCIATED WITH MATERNAL ANTIEPILEPTIC DRUGS , 1981, The Lancet.

[89]  M. R. Gomez.  Possible teratogenicity of valproic acid. , 1981, The Journal of pediatrics.

[90]  B. Dalens,et al.  Teratogenicity of valproic acid. , 1980, The Journal of pediatrics.

[91]  L. Pellegrini,et al.  [Dysmorphisms and psychomotor retardation in infants of mothers treated with anticonvulsants in pregnancy]. , 1979, Minerva pediatrica.

[92]  R. Freedom,et al.  A possible primidone embryopathy. , 1979, The Journal of pediatrics.

[93]  David W. Smith,et al.  Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. , 1976, The Journal of pediatrics.

[94]  M. Seip.  GROWTH RETARDATION, DYSMORPHIC FACIES AND MINOR MALFORMATIONS FOLLOWING MASSIVE EXPOSURE TO PHENOBARBITONE IN UTERO , 1976, Acta paediatrica Scandinavica.

[95]  JamesW. Hanson,et al.  FETAL HYDANTOIN SYNDROME , 1976, The Lancet.

[96]  S. Shapiro,et al.  Anticonvulsants and parental epilepsy in the development of birth defects. , 1976, Lancet.

[97]  M. Thaler,et al.  REYE'S SYNDROME , 1975, The Lancet.

[98]  S. Johansson,et al.  Letter: A radioimmunoassay for serum-alpha-fetoprotein based on commercial antisera. , 1974, Lancet.

[99]  M. Horning,et al.  Infants exposed in utero to antiepileptic drugs. A prospective study. , 1974, American journal of diseases of children.

[100]  S. Shapiro,et al.  Diphenylhydantoin and selected congenital malformations. , 1973, The New England journal of medicine.

[101]  H. Meinardi,et al.  Are anticonvulsants teratogenic? , 1973, Lancet.

[102]  J. South.  Teratogenic effect of anticonvulsants. , 1972, Lancet.

[103]  S. Meadow,et al.  Maternal epilepsy and abnormalities of the fetus and newborn. , 1972, Lancet.

[104]  D. Pruzansky,et al.  Are anticonvulsants teratogenic? , 1971, Lancet.

[105]  K. Ehlers,et al.  Trimethadione and human teratogenesis. , 1970, Teratology.

[106]  S. Meadow.  Anticonvulsant drugs and congenital abnormalities. , 1968, Lancet.

[107]  Saunders Kb.  END--OR BEGINNING? , 1965 .

[108]  W. Jb.  Government service and freedom. , 1947 .

[109]  C. Bearer.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .

[110]  C. Bearer.  Antiepileptic Drug Use of Women With Epilepsy and Congenital Malformations in Offspring , 2006 .

[111]  B. Tettenborn.  Management of Epilepsy in Women of Childbearing Age , 2006, CNS drugs.

[112]  B. Coull,et al.  The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. , 2005, The Journal of pediatrics.

[113]  T. Einarson,et al.  Malformation Rates in Children of Women with Untreated Epilepsy , 2004, Drug safety.

[114]  B. Kerr,et al.  Fetal valproate syndrome and autism , 2001 .

[115]  A. Ornoy,et al.  The use of psychiatric drugs in pregnancy and lactation. , 2000, The Israel journal of psychiatry and related sciences.

[116]  S. Ried,et al.  Epilepsy, Pregnancy and the Child , 1997 .

[117]  C. Bower,et al.  Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen. , 1996, Birth defects original article series.

[118]  S. Clarren,et al.  Verification of the fetal valproate syndrome phenotype. , 1988, American journal of medical genetics.

[119]  D. Janz.  Epilepsy, pregnancy, and the child , 1982 .

[120]  F. Majewski,et al.  The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. , 1981, International journal of biological research in pregnancy.

[121]  I. Strannegård,et al.  Letter: Transfer factor in severe atopic disease. , 1975, Lancet.

[122]  N. Bayley.  Manual for the Bayley Scales of Infant Development , 1969 .